| J3262 | Injection, tocilizumab, 1 mg | 60,200 | $10 | $301K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,030 | $30 | $272.9K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 17,080 | $10 | $187.8K |
| J0897 | Injection, denosumab, 1 mg | 5,220 | $20 | $94K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,250 | $30 | $84.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 570 | $100 | $58.8K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 330 | $60 | $19.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 160 | $100 | $16.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 190 | $80 | $14.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 70 | $140 | $9.1K |